In WHO grade III astrocytomas with the R132H mutation in IDH1, OCT4 expression levels were on average higher than in wild-type gliomas and were associated with a worse patient prognosis [19]. This evidence concerns the gene POU5F1 and astrocytoma (excluding glioblastoma).